Literature DB >> 25349652

Non-interventional management of resistant hypertension.

Michael Doumas1, Costas Tsioufis1, Charles Faselis1, Antonios Lazaridis1, Haris Grassos1, Vasilios Papademetriou1.   

Abstract

Hypertension is one of the most popular fields of research in modern medicine due to its high prevalence and its major impact on cardiovascular risk and consequently on global health. Indeed, about one third of individuals worldwide has hypertension and is under increased long-term risk of myocardial infarction, stroke or cardiovascular death. On the other hand, resistant hypertension, the "uncontrollable" part of arterial hypertension despite appropriate therapy, comprises a much greater menace since long-standing, high levels of blood pressure along with concomitant debilitating entities such as chronic kidney disease and diabetes mellitus create a prominent high cardiovascular risk milieu. However, despite the alarming consequences, resistant hypertension and its effective management still have not received proper scientific attention. Aspects like the exact prevalence and prognosis are yet to be clarified. In an effort to manage patients with resistant hypertension appropriately, clinical doctors are still racking their brains in order to find the best therapeutic algorithm and surmount the substantial difficulties in controlling this clinical entity. This review aims to shed light on the effective management of resistant hypertension and provide practical recommendations for clinicians dealing with such patients.

Entities:  

Keywords:  Adherence; Antihypertensive drugs; Resistant hypertension; Secondary hypertension; White coat hypertension

Year:  2014        PMID: 25349652      PMCID: PMC4209434          DOI: 10.4330/wjc.v6.i10.1080

Source DB:  PubMed          Journal:  World J Cardiol


  109 in total

1.  Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapies.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg
Journal:  JAMA       Date:  2004-07-07       Impact factor: 56.272

Review 2.  Renal sympathetic denervation in hypertension.

Authors:  Michael Doumas; Charles Faselis; Vasilios Papademetriou
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-11       Impact factor: 2.894

Review 3.  Resistant hypertension.

Authors:  Norman M Kaplan
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

5.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

6.  Prevalence of drug resistant hypertension.

Authors:  M H Alderman; N Budner; H Cohen; B Lamport; W L Ooi
Journal:  Hypertension       Date:  1988-03       Impact factor: 10.190

7.  Early predictors of 15-year end-stage renal disease in hypertensive patients.

Authors:  H M Perry; J P Miller; J R Fornoff; J D Baty; M P Sambhi; G Rutan; D W Moskowitz; S E Carmody
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

8.  Prognostic influence of office and ambulatory blood pressures in resistant hypertension.

Authors:  Gil F Salles; Claudia R L Cardoso; Elizabeth S Muxfeldt
Journal:  Arch Intern Med       Date:  2008-11-24

9.  Benefits from treatment and control of patients with resistant hypertension.

Authors:  Michael Doumas; Vasilios Papademetriou; Stella Douma; Charles Faselis; Konstantinos Tsioufis; Eugene Gkaliagkousi; Konstantinos Petidis; Chrysanthos Zamboulis
Journal:  Int J Hypertens       Date:  2010-12-22       Impact factor: 2.420

10.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

View more
  1 in total

1.  Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study.

Authors:  Alexandros Kasiakogias; Costas Tsioufis; Kyriakos Dimitriadis; Dimitrios Konstantinidis; Areti Koumelli; Ioannis Leontsinis; Eirini Andrikou; Nikos Vogiatzakis; Smaragdi Marinaki; Dimitrios Petras; Christos Fragoulis; Konstantinos Konstantinou; Vasilios Papademetriou; Dimitrios Tousoulis
Journal:  J Hum Hypertens       Date:  2018-05-01       Impact factor: 3.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.